publications-2007-2010

Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU

Published on 19 March 2015

Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU
Authors	Verbruggen A, Coenen HH, Deverre JR, Guilloteau D, Langstrom B, Salvadori PA, Halldin C
Journal	Eur. J. Nucl. Med. Mol. Imaging 35 (11), 2144-2151, 2008
Year	2008
Institute	I2BM

Retour à la liste

Top page

Alternative and Atomic Energies Agency

CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.

The Knowledge Factory

In the same section :

Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU

Browse the site

Alternative and Atomic Energies Agency

Browse the portal

The Knowledge Factory

About Fundamental Research Division

Research fields

Scientific results

In the same section :

Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU

Browse the site

Alternative and Atomic Energies Agency

Browse the portal